{"entity":{"id":"nct07034326","kind":"trial","name":"Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer","aka":[],"tldr":"A phase 2/3 trial in lung cancer, run by Kong Fanming, now recruiting.","summary":"Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer is a phase 2/3, randomised interventional study registered as NCT07034326 by Kong Fanming, with a registry enrolment figure of 405 participants, started 2025-01-01 and due to reach its primary completion in 2028-12-31. Interventions recorded: Electroacupuncture combined with immunotherapy; Zilongjin tablet combined with immunotherapy; Immunotherapy. Conditions listed: Non-Small Cell Lung Cancer; Electroacupuncture; Immune Checkpoint Inhibitors. Primary outcome: Disease free survival(DFS). Lung eligibility wording from the registry: \"* (1) Non-tumor patients with stage II, IIIA, IIIB (N2) non-small cell lung cancer diagnosed by pathology or cytology after surgery; (2) driver mutations negative patients; (3) Postoperative adjuvant chemotherapy was received for 1 to 4 cycles;(4)conforms to two qi syndrome of traditional Chinese me\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07034326","url":"https://clinicaltrials.gov/study/NCT07034326"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["resectable-nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07034326","phase":"2/3","setting":"Observation on the Clinical Efficacy of Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer","sponsor":"Kong Fanming","enrolled":405,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07034326/","neighbours":{"cancer":[{"id":"resectable-nsclc","kind":"cancer","name":"Resectable stage I to III non-small-cell lung cancer","route":"/cancers/resectable-nsclc/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}